Overview
Portfolio
More
VCapital Management
VCapital Management provides institutional‑grade venture capital alternatives to accredited investors and wealth advisors, offering boutique‑customized, diversified exposure to high‑quality venture opportunities. The fir...
Portfolio
9+
Employees
N/A
Founded
N/A
AUM
≈ $100.0M
Investment focus
Stages
No stages listed
Industries
Artificial IntelligenceBiotechnologyEnterprise SoftwareHealthcare Technology
Geographic scope
Global
Fund details
Funds
Batterson Technology Venture Partners
Vintage 1999 • $100.0M
Sources
VCapital Management
VCapital Management provides institutional‑grade venture capital alternatives to accredited investors and wealth advisors, offering boutique‑customized, diversified exposure to high‑quality venture opportunities. The firm focuses on sectors such as AI, biotech, quantum computing, healthtech, and enterprise software, seeking to generate strong returns through flexible minimum investments and active portfolio management.
Portfolio
9+
Employees
N/A
Founded
N/A
AUM
≈ $100.0M
Funds
Batterson Technology Venture Partners · Vintage 1999 • $100.0M
Stages
No stages listed
Industries
Artificial IntelligenceBiotechnologyEnterprise SoftwareHealthcare TechnologyQuantum Computing
Geographic scope
Global
Sources
Showing 9 of 9 matched portfolio companies
Ad Cast is a rideshare entertainment and advertising platform that utilizes in-vehicle digital displays to deliver targeted advertisements to passengers. This approach enhances the passenger experience while providing rideshare drivers with an additional revenue stream through ad placements.
3+
50+Approximate amount of employees
Organizes and streamlines room rental processes by providing a platform for listing, booking, and managing rental agreements. It simplifies the challenges of finding, securing, and paying for rental accommodations, ensuring a seamless experience for both renters and property owners.
Avenda Health utilizes artificial intelligence to create a Cancer Estimation Map (CEM) that accurately visualizes the location and extent of prostate cancer, significantly enhancing treatment planning. This technology helps physicians make informed decisions, reducing the likelihood of residual cancer and preserving patients' quality of life.
Funding: $19.3M
Rough estimate of the amount of funding raised
Funding: $19.3M
Rough estimate of the amount of funding raised
DIA provides a decentralized oracle platform that utilizes a rollup architecture to deliver real-time, verifiable data across over 50 blockchain networks, supporting more than 20,000 assets. This technology addresses the need for reliable and transparent data feeds in decentralized applications, enabling developers to integrate accurate price information without relying on third-party sources.
Funding: $50.0K
Rough estimate of the amount of funding raised
Funding: $50.0K
Rough estimate of the amount of funding raised
Intensity Therapeutics utilizes its proprietary DfuseRx℠ intratumoral delivery technology to inject therapeutic agents directly into solid tumors, enhancing drug absorption and promoting localized cancer cell death. This approach activates a systemic immune response, targeting both the primary tumor and metastatic sites, ultimately aiming to extend patient survival and reduce disease recurrence.
Funding: $3.0M
Rough estimate of the amount of funding raised
Funding: $3.0M
Rough estimate of the amount of funding raised
The startup operates a data analytics platform that enables rapid analysis of large datasets, handling tens of terabytes to exabytes with trillions of rows. By ingesting billions of rows per second and providing filtered aggregate results, the platform simplifies complex data ecosystems for organizations.
Funding: $147.7M
Rough estimate of the amount of funding raised
GreycroftOCA Ventures
GreycroftOCA Ventures
Funding: $147.7M
Rough estimate of the amount of funding raised
Quan provides a science-backed employee well-being platform that utilizes evidence-based assessments to measure dimensions of well-being, enabling teams to identify strengths and risks. By facilitating structured quarterly discussions and recommending targeted rituals, Quan helps organizations enhance team performance and prevent burnout.
Funding: $4.0M
Rough estimate of the amount of funding raised
Funding: $4.0M
Rough estimate of the amount of funding raised
Rejuvenate Bio utilizes gene therapy to develop treatments aimed at reversing aging and addressing chronic, age-related diseases that affect six in ten Americans. By targeting the underlying genetic factors of these conditions, the company aims to reduce the prevalence and healthcare costs associated with chronic diseases.
SentiAR has developed a holographic 3D visualization platform that provides real-time, interactive views of patient anatomy and catheter positioning during interventional procedures. This technology enhances procedural accuracy and efficiency by consolidating multiple data sources into a single, intuitive interface, enabling clinicians to deliver safer and more precise care.
Funding: $18.2M
Rough estimate of the amount of funding raised
cultivate(MD)
cultivate(MD)
Funding: $18.2M
Rough estimate of the amount of funding raised